GEN Exclusives

More »

GEN News Highlights

More »
Dec 20, 2006

OGT Grants DNA Sequence Variation Rights to Illumina

  • Illumina obtained permission to Oxford Gene Technology’s (OGT) patents for the detection of DNA sequence variations. The granted license will remain valid for the lifetime of the patents.

    Under the license agreement, Illumina gained certain rights with respect to SNP genotyping. “OGT’s technology combined with Illumina’s BeadArray™ technology gives customers access to an extremely powerful SNP detection platform,” says Sue Sutton, vp, Licensing North America at OGT.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?